We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04899271
Brief Title: A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

First Submitted : May 10, 2021
First Submitted that Met QC Criteria : May 21, 2021
First Posted : May 24, 2021

Last Update Submitted that Met QC Criteria : May 2, 2022
Last Update Posted : May 3, 2022